Dorota Bądziul

Dr. Dorota Bądziul

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 April 2013 in Tumor Biology
Verified
Journal Article
Open access
PDF file
JJJoanna Jakubowicz-Gil
Joanna Jakubowicz-Gil
ELEwa Langner
Ewa Langner
DBDorota Bądziul
Dorota Bądziul
Iwona WertelIwona Wertel
Iwona Wertel
WRWojciech Rzeski
Wojciech Rzeski
Glioblastoma multiforme is the most aggressive primary brain tumour. At the cellular and molecular levels, several mechanisms responsible for apoptosis or autophagy induction are blocked. Identification of molecular targets stimulating cells to initiate programmed cell death should be performed for therapeutic purposes. A promising solution is the combination of temozolomide and quercetin. The aim of our study was to evaluate the effect of both drugs, applied alone and in combinations, on apoptosis and autophagy induction in human glioblastoma multiforme T98G cells. Our results clearly indicate that quercetin and temozolomide induce apoptosis very significantly, having no effect on autophagy induction. At the molecular level, it was correlated with caspase 3 and 9 activation, cytochrome c release from the mitochondrium and a decrease in the mitochondrial membrane potential. Both drugs are also potent Hsp27 and Hsp72 inhibitors. This suggests that the apoptotic signal goes through an internal pathway. Increased expression of caspase 12 and the presence of several granules in the cytoplasm after temozolomide treatment with or without quercetin preceding appearance of apoptosis may suggest that apoptosis is initiated by ER stress. Additionally, it was accompanied by changes in the nuclear morphology from circular to ‘croissant like’.

1 December 2013 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
JJJoanna Jakubowicz-Gil
Joanna Jakubowicz-Gil
ELEwa Langner
Ewa Langner
DBDorota Bądziul
Dorota Bądziul
Iwona WertelIwona Wertel
Iwona Wertel
WRWojciech Rzeski
Wojciech Rzeski

24 December 2013 in Neurotoxicity Research
Verified
Journal Article
Open access
PDF file
JJJoanna Jakubowicz-Gil
Joanna Jakubowicz-Gil
ELEwa Langner
Ewa Langner
DBDorota Bądziul
Dorota Bądziul
Iwona WertelIwona Wertel
Iwona Wertel
WRWojciech Rzeski
Wojciech Rzeski
The aim of the present study was to investigate the effect of sorafenib and quercetin on the induction of apoptosis and autophagy in human anaplastic astrocytoma (MOGGCCM) and glioblastoma multiforme (T98G) cell lines. In MOGGCCM cells, sorafenib initiated mainly apoptosis, mediated by the mitochondrial pathway with mitochondrial membrane permeabilization, cytochrome c release to the cytoplasm, and activation of caspase 9 and 3. Additional incubation with quercetin potentiated the pro-apoptotic properties of sorafenib. In T98G cells, autophagy was observed most frequently after the sorafenib treatment. It was accompanied by increased beclin 1 and LC3II expression. Administration of quercetin after the sorafenib treatment resulted in an increased number of autophagic cells. After simultaneous drug application, the level of autophagy was lower in favour of apoptosis. Inhibition of heat shock proteins expression by specific small interfering RNA significantly increased the sensitivity of both the cell lines to induction of apoptosis, but not autophagy. We demonstrated for the first time that sorafenib and quercetin are very effective programmed cell death inducers in T98G and MOGGCCM cells, especially in cells with blocked expression of heat shock proteins.

30 March 2014 in Molecular and Cellular Biochemistry
Verified
Journal Article
Open access
PDF file
DBDorota Bądziul
Dorota Bądziul
JJJoanna Jakubowicz-Gil
Joanna Jakubowicz-Gil
RPRoman Paduch
Roman Paduch
KGKazimierz Głowniak
Kazimierz Głowniak
AGAntoni Gawron
Antoni Gawron
The aim of the present study was to assess the effect of quercetin and imperatorin administered separately and in combination on apoptosis and autophagy induction in human cervical carcinoma HeLa cells and laryngeal carcinoma Hep-2 cells cultured in vitro. Conducted MTT measurements proved that quercetin and imperatorin displayed a strong antiproliferative activity manifested in markedly reduction of HeLa and Hep-2 cells viability as a result of treatment with 50 μM of each compound. Further cell staining assays revealed that concentration mentioned above generated the highest percentage of apoptotic cells especially in the case of application of both drugs for 48 h. Simultaneous quercetin and imperatorin administration induced apoptosis remarkably stronger than treatment with single drugs. Experiments at the molecular level confirmed these results accompanied with the decreased Hsp27 and Hsp72 expression and, in addition, with increased caspases activity. Autophagy was not observed and no significant changes in the expression of beclin-1 were noticed. Additionally, experiments were performed on the above-mentioned cell lines with blocked Hsp27 and Hsp72 expression. In these cells, no significant changes in the sensitivity to apoptosis induction upon quercetin and imperatorin treatment were observed. The present study has provided evidence supporting the potential of the combination of quercetin and imperatorin drugs as a novel tool to be used in anticancer therapy. Our results have also demonstrated that blocking of the Hsp27 and Hsp72 gene expression is not enough to sensitize cancer cells to programmed cell death induction in HeLa and Hep-2 cells.

1 August 2017 in Pharmacological Reports
Verified
Journal Article
Closed access
JJJoanna Jakubowicz-Gil
Joanna Jakubowicz-Gil
DBDorota Bądziul
Dorota Bądziul
ELEwa Langner
Ewa Langner
Iwona WertelIwona Wertel
Iwona Wertel
AZAdrian Zając
Adrian Zając
WRWojciech Rzeski
Wojciech Rzeski

Verified
Journal Article
Open access
PDF file
AZAdrian Zając
Adrian Zając
JSJoanna Sumorek-Wiadro
Joanna Sumorek-Wiadro
ELEwa Langner
Ewa Langner
Iwona WertelIwona Wertel
Iwona Wertel
AMAleksandra Maciejczyk
Aleksandra Maciejczyk
JJJoanna Jakubowicz-Gil
Joanna Jakubowicz-Gil
The aim of the study was to investigate the anticancer potential of LY294002 (PI3K inhibitor) and temozolomide using glioblastoma multiforme (T98G) and anaplastic astrocytoma (MOGGCCM) cells. Apoptosis, autophagy, necrosis, and granules in the cytoplasm were identified microscopically (fluorescence and electron microscopes). The mitochondrial membrane potential was studied by flow cytometry. The activity of caspases 3, 8, and 9 and Akt was evaluated fluorometrically, while the expression of Beclin 1, PI3K, Akt, mTOR, caspase 12, and Hsp27 was determined by immunoblotting. SiRNA was used to block Hsp27 and PI3K expression. Cell migration and localization of Hsp27 were tested with the wound healing assay and immunocytochemistry, respectively. LY294002 effectively diminished the migratory potential and increased programmed death of T98G and MOGGCCM. Autophagy was dominant in MOGGCCM, while apoptosis was dominant in T98G. LY294002 with temozolomide did not potentiate cell death but redirected autophagy toward apoptosis, which was correlated with ER stress. A similar effect was observed after blocking PI3K expression with siRNA. Transfection with Hsp27 siRNA significantly increased apoptosis related to ER stress. Our results indicate that inhibition of the PI3K/Akt/mTOR pathway sensitizes glioma cells to apoptosis upon temozolomide treatment, which was correlated with ER stress. Hsp27 increases the resistance of glioma cells to cell death upon temozolomide treatment.